Before revision: We investigate the emerging scenarios from a two-population Susceptible-Infected-Recovered-Asymptomatic-Symptomatic-Dead (SIRASD)
After revision: We investigate the emerging scenarios from a Susceptible-Infected-Recovered-Asymptomatic-Symptomatic-Dead (SIRASD)